Low Dose Cyclophosphamide Rescues Myocardial Function from Ischemia-Reperfusion in Rats

Jianhua Zhu,Yuangang Qiu,Qiqi Wang,Yujuan Zhu,Shenjiang Hu,Liangrong Zheng,Lihong Wang,Yun Zhang

DOI: https://doi.org/10.1016/j.ejcts.2008.05.035

IF: 4.534

2008-01-01

European Journal of Cardio-Thoracic Surgery

Abstract:Objectives: The effect of low dose of cyclophosphamide (CP) protecting cardiac function from ischemia-reperfusion injury was studied on rats. The premise is that CP inhibits immune and inflammatory process, thereby limits I/R injury and improves myocardial function. Methods: Open chest rats were submitted to 30 min of ischemia followed by 3 h, 12 h or 24 h of reperfusion. Rats were divided into sham group, I/R group and CP group, and each group included 3 time-point subgroups Q h, 12 h and 24 h; n = 8 for each subgroup). A total of 750 mg/m(2) cyclophosphamide was intraperitoneally administrated in CP group and saline was given to I/R group. A polyethylene tube was inserted into the left ventricular cavity to detect left ventricular systolic pressure (LVSP) and +/- dp/dt(max). At the end of the experiment, hearts were harvested for histopathological assessment and infarct size determination. Results: Compared with I/R group, rats treated with low dose CP showed a significant recovery in myocardial function with improved LVSP (88 +/- 11 vs 69 +/- 11 mmHg of 3 h; 92 +/- 11 vs 64 +/- 14 mmHg of 12 h; 90 +/- 11 vs 64 +/- 14 mmHg of 24 h; p < 0.01 respectively). The +/- dp/dt(max) also had the similar trends. The myocardial infarct size was reduced in CP group compared to that in I/R group; the infiltration of polymorph nuclear leukocytes (PMNs) in myocardium was decreased in CP group. The histopathological. damage score was also attenuated. Conclusions: These findings suggest that low dose CP rescues cardiac function from ischemia-reperfusion injury by alleviating histopathological. damage in rat myocardium. (c) 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.